New CDMO Facility
Leveraging a State-of-the-Art CDMO Facility to Advance Healthcare
Grifols
PAO-02-23-PATV-04Feb 23, 2023
CAPA Management
CAPA Management is Worth Doing, and Worth Doing Well
Helen Lowe
PAO-04-022-CL-11May 04, 2022
Regulatory
FDA Makes Low-Risk Determination for Marketing of Products from Genome-Edited Beef Cattle After Safety Review
U.S. Food & Drug Administration
PR-M03-22-03Mar 07, 2022
Nitrosamine
Supporting Drug Manufacturers with Emprove® Nitrosamine Declarations
Ulrich Reichert, M.D.R.A.
MilliporeSigma
PAO-02021-CL-05Feb 10, 2021
Roundtable
Q: Although there is no such thing as a truly “crisis-proof” organization, how are you working to mitigate risks for future crises like the COVID-19 pandemic?
Pharma's Almanac
PAP-Q4-20-NI-007Dec 09, 2020
Equipment
Fit Biopharmaceutical Facilities: A Predictive Maintenance Approach
CRB USA
PAP-Q2-17-CL-010Jun 05, 2017
Keeping it Clean
Nice Insight
PTV-M11-16-AP-005Apr 06, 2017